Published in Am J Ophthalmol on August 15, 1989
A test of a linear model of glaucomatous structure-function loss reveals sources of variability in retinal nerve fiber and visual field measurements. Invest Ophthalmol Vis Sci (2009) 1.96
Frequency of testing for detecting visual field progression. Br J Ophthalmol (2002) 1.77
Spatial pattern of glaucomatous visual field loss obtained with regionally condensed stimulus arrangements. Invest Ophthalmol Vis Sci (2010) 1.72
'Structure-function relationship' in glaucoma: past thinking and current concepts. Clin Experiment Ophthalmol (2012) 1.53
Detection of optic disc change with the Heidelberg retina tomograph before confirmed visual field change in ocular hypertensives converting to early glaucoma. Br J Ophthalmol (1999) 1.46
A new pattern electroretinogram paradigm evaluated in terms of user friendliness and agreement with perimetry. Ophthalmology (2007) 1.28
Linearity can account for the similarity among conventional, frequency-doubling, and gabor-based perimetric tests in the glaucomatous macula. Optom Vis Sci (2006) 1.26
Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials. Invest Ophthalmol Vis Sci (2012) 1.26
Effect of glaucomatous damage on repeatability of confocal scanning laser ophthalmoscope, scanning laser polarimetry, and optical coherence tomography. Invest Ophthalmol Vis Sci (2007) 1.21
Assessment of the reliability of standard automated perimetry in regions of glaucomatous damage. Ophthalmology (2014) 1.18
Evaluation of a two-stage neural model of glaucomatous defect: an approach to reduce test-retest variability. Optom Vis Sci (2006) 1.12
Factors predicting the rate of functional progression in early and suspected glaucoma. Invest Ophthalmol Vis Sci (2012) 1.04
Variability of visual field measurements is correlated with the gradient of visual sensitivity. Vision Res (2007) 1.02
Visual field test simulation and error in threshold estimation. Br J Ophthalmol (1996) 0.98
Rapid pupil-based assessment of glaucomatous damage. Optom Vis Sci (2008) 0.96
Contrast sensitivity perimetry and clinical measures of glaucomatous damage. Optom Vis Sci (2014) 0.95
Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. Arch Ophthalmol (2005) 0.95
Correlating RNFL thickness by OCT with perimetric sensitivity in glaucoma patients. J Glaucoma (2012) 0.94
Progression of patterns (POP): a machine classifier algorithm to identify glaucoma progression in visual fields. Invest Ophthalmol Vis Sci (2012) 0.93
Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications. Graefes Arch Clin Exp Ophthalmol (2011) 0.93
The Effect of Stimulus Size on the Reliable Stimulus Range of Perimetry. Transl Vis Sci Technol (2015) 0.91
Measurement error of visual field tests in glaucoma. Br J Ophthalmol (2003) 0.88
Progression detection in different stages of glaucoma: mean deviation versus visual field index. Jpn J Ophthalmol (2011) 0.87
Pupillary evaluation of retinal asymmetry: development and initial testing of a technique. Vision Res (2005) 0.86
Imaging Glaucomatous Damage Across the Temporal Raphe. Invest Ophthalmol Vis Sci (2015) 0.85
The effect of pilocarpine on the glaucomatous visual field. Br J Ophthalmol (1993) 0.84
Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study. Ophthalmology (2013) 0.84
New insights into measurement variability in glaucomatous visual fields from computer modelling. PLoS One (2013) 0.83
A comparison of automated static dark stimuli with the Humphrey STATPAC program in glaucomatous visual field loss. Br J Ophthalmol (1994) 0.82
Pattern electroretinogram and automated perimetry in patients with glaucoma and ocular hypertension. Br J Ophthalmol (1994) 0.81
Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangements. Graefes Arch Clin Exp Ophthalmol (2009) 0.81
Glaucoma detection with matrix and standard achromatic perimetry. Br J Ophthalmol (2007) 0.81
Relationships of retinal structure and humphrey 24-2 visual field thresholds in patients with glaucoma. Invest Ophthalmol Vis Sci (2014) 0.81
Relationship between spectral-domain optical coherence tomography and standard automated perimetry in healthy and glaucoma patients. Biomed Res Int (2014) 0.79
Choice of Stimulus Range and Size Can Reduce Test-Retest Variability in Glaucomatous Visual Field Defects. Transl Vis Sci Technol (2014) 0.78
Five-year forecasts of the Visual Field Index (VFI) with binocular and monocular visual fields. Graefes Arch Clin Exp Ophthalmol (2012) 0.78
Assessment of Central Retinal Sensitivity Employing Two Types of Microperimetry Devices. Transl Vis Sci Technol (2014) 0.78
Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma. Prog Retin Eye Res (2016) 0.77
Automated perimetry: using gaze-direction data to improve the estimate of scotoma edges. Invest Ophthalmol Vis Sci (2011) 0.77
Modeling the relative influence of fixation and sampling errors on retest variability in perimetry. Graefes Arch Clin Exp Ophthalmol (2014) 0.77
Assessment of the optic disc morphology using spectral-domain optical coherence tomography and scanning laser ophthalmoscopy. Biomed Res Int (2014) 0.77
Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies. Trans Am Ophthalmol Soc (2002) 0.76
Stimulus size for perimetry in patients with glaucoma. Invest Ophthalmol Vis Sci (2013) 0.76
Detection of Visual Field Loss in Pituitary Disease: Peripheral Kinetic Versus Central Static. Neuroophthalmology (2015) 0.75
Prevalence and spatial concordance of visual field deterioration in fellow eyes of glaucoma patients. Korean J Ophthalmol (2014) 0.75
A comparison of Goldmann III, V and spatially equated test stimuli in visual field testing: the importance of complete and partial spatial summation. Ophthalmic Physiol Opt (2017) 0.75
Effect of a variability-adjusted algorithm on the efficiency of perimetric testing. Invest Ophthalmol Vis Sci (2014) 0.75
Correlating perimetric indices with three nerve fiber layer thickness measures. Optom Vis Sci (2013) 0.75
Pattern visual evoked potential in ocular hypertension. Br J Ophthalmol (1991) 0.75
Long-term variability in short-wavelength automated perimetry compared to standard perimetry in glaucoma patients and normal subjects. Oman J Ophthalmol (2009) 0.75
Estimating OCT Structural Measurement Floors to Improve Detection of Progression In Advanced Glaucoma. Am J Ophthalmol (2016) 0.75
The Effect of Attentional Cueing and Spatial Uncertainty in Visual Field Testing. PLoS One (2016) 0.75
Intersession test-retest variability of 10-2 MAIA microperimetry in fixation-threatening glaucoma. Clin Ophthalmol (2017) 0.75
Reducing variability in visual field assessment for glaucoma through filtering that combines structural and functional information. Invest Ophthalmol Vis Sci (2014) 0.75
Lack of Visual Field Improvement After Initiation of Intraocular Pressure Reducing Treatment in the Early Manifest Glaucoma Trial. Invest Ophthalmol Vis Sci (2016) 0.75
The value of visual field testing in the era of advanced imaging: clinical and psychophysical perspectives. Clin Exp Optom (2017) 0.75
Frequency doubling illusion VEPs and automated perimetry in multiple sclerosis. Doc Ophthalmol (2006) 0.75
Optical Coherence Tomography Analysis Based Prediction of Humphrey 24-2 Visual Field Thresholds in Patients With Glaucoma. Invest Ophthalmol Vis Sci (2017) 0.75
[Current state of pupil-based diagnostics for glaucomatous optic neuropathy]. Ophthalmologe (2012) 0.75
Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease: results from the Early Manifest Glaucoma Trial. Acta Ophthalmol (2016) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (1993) 9.88
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol (1987) 3.22
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Fitness loss and germline mutations in barn swallows breeding in Chernobyl. Nature (1997) 2.00
Height, weight and menarche in Swedish urban school children in relation to socio-economic and regional factors. Ann Hum Biol (1976) 1.87
Visual field interpretation with empiric probability maps. Arch Ophthalmol (1989) 1.74
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clin Chem (1995) 1.71
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61
Local breast cancer recurrence caused by mammographically guided punctures. Acta Radiol (2000) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity. J Epidemiol Community Health (2001) 1.52
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol (1997) 1.51
Prevalence and intensity of pain after stroke: a population based study focusing on patients' perspectives. J Neurol Neurosurg Psychiatry (2005) 1.48
Scientific rigour in qualitative research--examples from a study of women's health in family practice. Fam Pract (1994) 1.44
Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.42
Addition of calcium to Euro-Collins solution is essential for 24-hour preservation of the vasculature. Ann Thorac Surg (1997) 1.41
Vitamin B12 metabolism after urinary diversion with a Kock ileal reservoir. Scand J Urol Nephrol (2001) 1.39
[A complication in Budd-Chiari syndrome. Heparin therapy caused thrombocytopenia]. Lakartidningen (1994) 1.39
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ (1989) 1.39
The effect of perimetric experience in normal subjects. Arch Ophthalmol (1989) 1.38
Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients. Rhinology (1998) 1.33
Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke (2001) 1.26
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25
Requirement for coenzyme Q in plasma membrane electron transport. Proc Natl Acad Sci U S A (1992) 1.25
Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol (2001) 1.23
Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 1.17
Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis (2008) 1.17
Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat (1996) 1.16
Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol (1995) 1.15
Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand (1997) 1.14
Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol Scand (2007) 1.09
Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med (1994) 1.09
Risk factors for local recurrence after breast-conserving surgery. Br J Surg (2003) 1.08
Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet (1999) 1.07
Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology (1995) 1.07
"I've been crying my way"--qualitative analysis of a group of female patients' consultation experiences. Fam Pract (1996) 1.07
Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry (1989) 1.07
International Equine Gene Mapping Workshop Report: a comprehensive linkage map constructed with data from new markers and by merging four mapping resources. Cytogenet Genome Res (2005) 1.05
Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med (1995) 1.03
Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med (2000) 0.99
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates. Cytometry (1995) 0.97
Subdivision of the G1 phase of human glia cells in culture. Exp Cell Res (1976) 0.97
Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry (2000) 0.97
Persistent high signal on diffusion-weighted MRI in the late stages of small cortical and lacunar ischaemic lesions. Neuroradiology (2001) 0.97
Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2000) 0.97
Autoradiographic studies on the distribution of arsenic in mice and hamsters administered 74As-arsenite or -arsenate. Acta Pharmacol Toxicol (Copenh) (1982) 0.97
"I was always on guard"--an exploration of woman abuse in a group of women with musculoskeletal pain. Fam Pract (1999) 0.96
Prognostic implication of estrogen receptor content in breast cancer. Breast Cancer Res Treat (1985) 0.96
Occupational exposures and risk of gastric cancer in a population-based case-control study. Cancer Res (1999) 0.95
Diet and risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1993) 0.95
Association of a lack of psychosocial resources and the risk of giving birth to small for gestational age infants: a stress hypothesis. BJOG (2000) 0.95
Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. J Clin Oncol (2004) 0.95
Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol (Copenh) (1984) 0.94
Increased stroke incidence in Lund-Orup, Sweden, between 1983 to 1985 and 1993 to 1995. Stroke (2000) 0.93
Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system. J Bioenerg Biomembr (1987) 0.93
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden. Haemophilia (2004) 0.93
Thermal homeostasis of resting man in helium-oxygen at 1-50 atmospheres absolute. Undersea Biomed Res (1975) 0.93
p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings. J Clin Oncol (1995) 0.93
Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat (2001) 0.93
Genetical and physical assignments of equine microsatellites--first integration of anchored markers in horse genome mapping. Mamm Genome (1997) 0.92
Liver involvement in Addison's disease. Am J Gastroenterol (1990) 0.92
Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J Biol Chem (1995) 0.92
Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet Pathol (1993) 0.92
Can endoscopic biopsy specimens be used for reliable Laurén classification of gastric cancer? Scand J Gastroenterol (1996) 0.92
Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major and Orthosiphon stamineus). J Ethnopharmacol (1992) 0.92
Report of the International Equine Gene Mapping Workshop: male linkage map. Anim Genet (1999) 0.92
Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest (1992) 0.92
Alternative surfaces for microcarrier culture of animal cells. Dev Biol Stand (1981) 0.91
The meanings of pain: an exploration of women's descriptions of symptoms. Soc Sci Med (1999) 0.91
Pleural plaques: correlation of autopsy findings to radiographic findings and occupational history. Eur J Respir Dis (1980) 0.91
Effects of a health screening on mortality and causes of death in middle-aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scand J Soc Med (1977) 0.91
Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. Restoration with thymic transplantation or administration of cytokines. J Immunol (1993) 0.90
Accumulation of toxic metals in male reproduction organs. Arch Toxicol Suppl (1984) 0.90
The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Acta Obstet Gynecol Scand (1986) 0.90
Perimetric threshold variability and age. Arch Ophthalmol (1988) 0.90
Cardiac changes in stroke patients and controls evaluated with transoesophageal echocardiography. Scand Cardiovasc J (1997) 0.89
Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol (1993) 0.89
Pure motor stroke from presumed lacunar infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke (2001) 0.88
The secular trend in physical growth in Sweden. Ann Hum Biol (1974) 0.88
Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol (1996) 0.88
Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea. Eur J Gastroenterol Hepatol (2000) 0.88
Magnetic resonance imaging and histopathology in dementia, clinically of frontotemporal type. Dement Geriatr Cogn Disord (2000) 0.88
Hyperhomocysteinaemia--a common finding in a psychogeriatric population. Eur J Clin Invest (1996) 0.88
Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation. Blood (1997) 0.88
Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden. Br J Cancer (2000) 0.88
Growth of schoolchildren with early, average and late ages of peak height velocity. Ann Hum Biol (1978) 0.87